RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
AVITA Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$13.14+0.10 (+0.77%)
Close on Oct 19, 2026
- Market cap
- $404.05M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$9.15 (+229.3%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
AVITA Medical, Inc. grew revenue 1.0% to $75.63M over the twelve months to Jun 30, 2026. Free cash flow was -$24.62M.
Revenue
$75.63M
+1.0% vs. a year earlier
Operating income
-$35.22M
TTM Q2 2026
Free cash flow
-$24.62M
TTM Q2 2026
EPS, diluted
-$1.44
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $404.05M
- P/E ratio
- –
- Price to sales
- 5.34
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -6.09%
Fundamentals
- Revenue
- $75.63M
- Net income
- -$43.08M
- EPS, diluted
- -$1.44
- Free cash flow
- -$24.62M
- Book value per share
- -$0.91
- Diluted shares
- 31M
Eight years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$75.63M+1.0% YoY
Gross profit
$61.68M-2.3% YoY
Operating income
-$35.22M
Net income
-$43.08M
EPS, diluted
-$1.44
Free cash flow
-$24.62M
Reported periodTrailing twelve months